MSB 7.69% $1.19 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-169

  1. 2,714 Posts.
    lightbulb Created with Sketch. 1804
    Great to see #MSC therapy continue to demonstrate its efficacy not only against #covidー19, but now against #MIS in #children. Looking forward to seeing the results from a larger clinical cohort. #sars2#sars_cov_2#C#covid19researchOVID

    There you go Doc Mc- I googled a world wide expert , I copied his tweet from 8 hours ago. Now I’ve pasted it for you to read.

    Someone needs to tell this bloke to stop saying Msc therapy is effective against Covid-19. He’s on the global Covid-19 taskforce, must be a deluded soul. Then he has the audacity to say it’s demonstrating efficacy in kids with Mis-c, drag him out and stone him. What witchcraft is this?

    Seriously I could turn for young Yan ,

    am I allowed to say that these days?

    Reg

    Come on Ards results !!!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.